Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET

Journal of Nuclear Medicine

Volumn 49, Issue 9, 2008, Pages 1520-1528

  Reshef, Ayelet ^a   Shirvan, Anat ^a   Waterhouse, Rikki N ^b   Grimberg, Hagit ^a   Levin, Galit ^a   Cohen, Avi ^a   Ulysse, Luckner G ^c   Friedman, Gad ^a   Antoni, Gunnar ^d   Ziv, Ilan ^a  

^a NeuroSurvival Technologies NST Ltd   (Israel)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Albany Molecular Research Institute   (United States)

^d Uppsala Imanet   (Sweden)

Author keywords

Apoptosis; Experimental stroke; Middle cerebral artery occlusion; PET imaging

Indexed keywords

FLUORINE 18 5 FLUOROPENTYL 2 METHYL MALONIC ACID; MESYLIC ACID; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SYNTHESIS; DRUG UPTAKE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MIDDLE CEREBRAL ARTERY; MOLECULAR IMAGING; MOUSE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; MALE; METHYLMALONIC ACID; MOLECULAR PROBE TECHNIQUES; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; STROKE;

EID: 51349157610     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.043919     Document Type: Article

References (28)

1. Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol. 2006;38:1834-1840.
2. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle. 2007;6:686-695.
3. Kametsu Y, Osuga S, Hakim AM. Apoptosis occurs in the penumbra zone during short-duration focal ischemia in the rat. J Cereb Blood Flow Metab. 2003;23:416-422.
4. Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res. 2006;1103:13-19.
5. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 2000;10:283-292.
6. Boersma HH, Kietselaer BL, Stolk LM, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med. 2005;46:2035-2050.
7. Aloya R, Shirvan A, Grimberg H, et al. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis. 2006;11:2089-2101.
8. Damianovich M, Ziv I, Heyman SN, et al. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging. 2006;33:281-291.
9. Reshef A, Shirvan A, Grimberg H, et al. Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res. 2007;1144:156-164.
10. National Institute of Neurological Disorders and Stroke. Report of the Stroke Progress Review Group. 2002:1-116. Available at: http://www.ninds.nih. gov/find_people/groups/stroke_prg/04_2002_stroke_prg_report.htm#executive. Accessed July 29, 2008.
11. Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 2001;6:69-81.
12. Guegan C, Sola B. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res. 2000;856:93-100.
13. Garcia JH, Liu KF, Ye ZR, Gutierrez JA. Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats. Stroke. 1997;28:2303-2309.
14. Noor R, Wang CX, Shuaib A. Hyperthermia masks the neuroprotective effects of tissue plaminogen activator. Stroke. 2005;36:665-669.
15. Lo EH, Broderick JP, Moskowitz MA. tPA and proteolysis in the neurovascular unit. Stroke. 2004;35:354-356.
16. Guegan C, Ceballos-Picot I, Nicole A, Kato H, Onteniente B, Sola B. Recruitment of several neuroprotective pathways after permanent focal ischemia in mice. Exp Neurol. 1998;154:371-380.
17. Thal SC, Engelhard K, Werner C. New cerebral protection strategies. Curr Opin Anaesthesiol. 2005;18:490-495.
18. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer. 2004;4:592-603.
19. Ito Y, Shibata MA, Kusakabe K, Otsuki Y. Method of specific detection of apoptosis using formamide-induced DNA denaturation assay. J Histochem Cytochem. 2006;54:683-692.
20. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997;185:1481-1486.
21. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001;2:589-598.
22. Schlaug G, Benfield A, Baired AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
23. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol. 1999;46:568-578.
24. Hossmann KA, Fischer M, Bockhorst K, Hoehn-Berlage M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J Cereb Blood Flow Metab. 1994;14:723-731.
25. Evelhoch JL, Gillies RJ, Karczmar GS, et al. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000;2:152-165.
26. Morse DL, Galons JP, Payne CM, et al. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed. 2007;20:602-614.
27. Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology. 1997;49:113-119.
28. Lundqvist H, Antoni G, Langstrom B. Genotoxic hazard of radiopharmaceuticals in humans: chemical and radiation aspects coupled to microdosing. Eur J Clin Pharmacol. 2007;63:641-645.